How big is the Drug Screening Market?

The Drug Screening Market size is expected to reach USD 7.30 billion in 2024 and grow at a CAGR of 16.36% to reach USD 15.60 billion by 2029. Read More

What is the current Drug Screening Market size?

In 2024, the Drug Screening Market size is expected to reach USD 7.30 billion. Read More

Who are the key players in Drug Screening Market?

Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Siemens Healthineers and LabCorp (Laboratory Corporation of America Holdings) are the major companies operating in the Drug Screening Market. Read More

Which is the fastest growing region in Drug Screening Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Drug Screening Market?

In 2024, the North America accounts for the largest market share in Drug Screening Market. Read More

What years does this Drug Screening Market cover, and what was the market size in 2023?

In 2023, the Drug Screening Market size was estimated at USD 6.11 billion. The report covers the Drug Screening Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Drug Screening Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Drug Screening Market - Share, Size & Analysis

Drug Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Drug Screening Market Report is Segmented by Product and Service (Consumables, Instruments, Rapid Testing Devices, and Services), Sample Type (Urine Samples, Oral Fluid Samples, Hair Samples, and Other Samples), End User (Drug Testing Laboratories, Hospitals, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East Africa, and South America). The Market Sizes and Forecasts are Provided in Terms of Value (USD) for the Above Segments.

Drug Screening Industry Overview

The drug screening market is semi-consolidated in nature due to the presence of several companies operating globally and regionally. The companies are involved in various strategic activities such as product launches, collaborations, and acquisitions. Key players operating in the global drug screening market are LabCorp (Laboratory Corporation of America Holdings), Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific Inc., Alfa Scientific Designs Inc., OraSure Technologies Inc., Siemens Healthineers, F. Hoffmann-La Roche Ltd, Shimadzu Corporation, LifeLock Technologies, Drägerwerk AG & Co. KGaA, and Premier Biotech Inc.